Cargando…

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis

We investigated the association between early tumor shrinkage (ETS) and treatment outcome in patients with hepatocellular carcinoma treated with lenvatinib (LEN). A retrospective analysis was performed in 104 patients. ETS was defined as tumor shrinkage at the first evaluation in the sum of target l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Aya, Moriguchi, Michihisa, Seko, Yuya, Shima, Toshihide, Mitsumoto, Yasuhide, Takashima, Hidetaka, Kimura, Hiroyuki, Fujii, Hideki, Ishikawa, Hiroki, Yo, Takaharu, Ishiba, Hiroshi, Morita, Atsuhiro, Jo, Masayasu, Nagao, Yasuyuki, Arai, Masahiro, Hara, Tasuku, Okajima, Akira, Muramatsu, Akira, Yoshinami, Naomi, Nakajima, Tomoki, Mitsuyoshi, Hironori, Umemura, Atsushi, Nishikawa, Taichiro, Yamaguchi, Kanji, Okanoue, Takeshi, Itoh, Yoshito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140019/ https://www.ncbi.nlm.nih.gov/pubmed/32209994 http://dx.doi.org/10.3390/cancers12030754

Ejemplares similares

Enhanced Antitumor Effect in Liver Cancer by Amino Acid Depletion-Induced Oxidative Stress
por: Okuda, Keiichiro, et al.
Publicado: (2021)

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
por: Kataoka, Seita, et al.
Publicado: (2021)

Potential Therapeutic Targets and Promising Agents for Combating NAFLD
por: Umemura, Atsushi, et al.
Publicado: (2022)

Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
por: Okuda, Keiichiro, et al.
Publicado: (2021)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
por: Seko, Yuya, et al.
Publicado: (2018)

Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan
por: Sumida, Yoshio, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells
por: Takahashi, Aya, et al.
Publicado: (2021)

Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice
por: Taketani, Hiroyoshi, et al.
Publicado: (2019)

Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan
por: Yano, Kota, et al.
Publicado: (2020)

FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
por: Seko, Yuya, et al.
Publicado: (2019)

PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat
por: Okishio, Shinya, et al.
Publicado: (2020)

The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals
por: Seko, Yuya, et al.
Publicado: (2020)

Comparison of portal vein hemodynamics with ultrasound-based elastography for the prediction of liver fibrosis in patients with chronic liver disease
por: Yamaguchi, Kanji, et al.
Publicado: (2023)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
por: Seko, Yuya, et al.
Publicado: (2020)

The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease
por: Seko, Yuya, et al.
Publicado: (2021)

Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach
por: Soda, Tomohiro, et al.
Publicado: (2022)

Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions
por: Fujii, Hideki, et al.
Publicado: (2017)

The additive effect of genetic and metabolic factors in the pathogenesis of nonalcoholic fatty liver disease
por: Seko, Yuya, et al.
Publicado: (2022)

EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma
por: Yasui, Kohichiroh, et al.
Publicado: (2015)

The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis
por: Muraishi, Nozomu, et al.
Publicado: (2023)

Straining Graphene Using Thin Film Shrinkage Methods
por: Shioya, Hiroki, et al.
Publicado: (2014)

Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C
por: Mitsuyoshi, Hironori, et al.
Publicado: (2013)

Mitochondrial Nutrition as a Strategy for Neuroprotection in Parkinson's Disease—Research Focus in the Department of Alternative Medicine and Experimental Therapeutics at Hokuriku University
por: Mitsumoto, Yasuhide
Publicado: (2007)

Correction to: Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM‑free AIM
por: Shimizu, Tomo, et al.
Publicado: (2022)

Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM
por: Shimizu, Tomo, et al.
Publicado: (2022)

On Reverse Shrinkage Effects and Shrinkage Overshoot
por: Jordan, Pascal
Publicado: (2022)

Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
por: Ishiba, Hiroshi, et al.
Publicado: (2020)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
por: Mizokami, Ken, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE
por: Qu, Shuping, et al.
Publicado: (2023)

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
por: Hyogo, Yasuko, et al.
Publicado: (2018)

Shrinkage estimation
por: Fourdrinier, Dominique, et al.
Publicado: (2018)

The Shrinkage of Amalgams
por: Fletcher, Thomas
Publicado: (1899)

Mechanism of Shrinkage in Compacted Graphite Iron and Prediction of Shrinkage Tendency
por: Liu, Zeyu, et al.
Publicado: (2022)

Garcin Syndrome Due to Meningeal Carcinomatosis from Gastric Cancer
por: Terasaki, Kei, et al.
Publicado: (2020)

Regression shrinkage and selection via least quantile shrinkage and selection operator
por: Daneshvar, Alireza, et al.
Publicado: (2023)

Degree of Conversion and Polymerization Shrinkage of Low Shrinkage Bulk-Fill Resin Composites
por: Salem, Haidy N., et al.
Publicado: (2019)

Surgical treatment of locally advanced papillary thyroid carcinoma after response to lenvatinib: A case report
por: Tsuboi, Mitsuhiro, et al.
Publicado: (2017)

Specific Shrinkage of Carotid Forks in Moyamoya Disease: A Novel Key Finding for Diagnosis
por: KURODA, Satoshi, et al.
Publicado: (2015)

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers
por: Kawaguchi, Takahisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6lal0ph99lipgq8j1po7rm27b3